Cidara Therapeutics Inc. (CDTX)
19.99
-0.93 (-4.45%)
At close: Jan 15, 2025, 11:17 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -3.03 | -1.77 | -1.52 | -1.15 | -2.87 | -1.03 | -2.14 | -3.13 | -7.34 | -1.1 | -3.85 | -7.16 |
| PS Ratio | 1.09 | 0.82 | 1.34 | 6.89 | 5.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -8.46 | -18.2 | 3.09 | 7.76 | 3.04 | 1.03 | 1.99 | 1.71 | 2.27 | 0.62 | -3.7 | -87.22 |
| P/FCF Ratio | -3.03 | -1.85 | -2.63 | -1.52 | -4.02 | -1.07 | -2.37 | -3.75 | -8.71 | -1.51 | -4.94 | n/a |
| P/OCF Ratio | -3.09 | -1.86 | -2.64 | -1.53 | -4.03 | -1.07 | -2.38 | -3.79 | -9.1 | -1.7 | -4.94 | n/a |
| OCF/S Ratio | -0.35 | -0.44 | -0.51 | -4.51 | -1.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -0.59 | -0.45 | 0.23 | 0.74 | 0.31 | 0.17 | 0.17 | 0.11 | n/a | n/a | -1.06 | n/a |
| Quick Ratio | 0.81 | 1.50 | 2.18 | 1.48 | 2.36 | 3.88 | 6.45 | 11.83 | 18.11 | 7.16 | 1.71 | 0.01 |
| Current Ratio | 0.90 | 1.50 | 2.11 | 1.48 | 2.18 | 3.88 | 6.43 | 11.83 | 18.11 | 7.16 | 1.71 | 0.01 |
| Asset Turnover | 0.95 | 1.35 | 0.66 | 0.20 | 0.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | -155.59 | -199.32 | -274.23 | -188.8 | -100.61 | -7.96K | -178.73 | -269.27 | n/a | n/a | n/a |
| Return on Equity (ROE) | 2.79 | 10.26 | -2.04 | -6.75 | -1.06 | -1 | -0.93 | -0.55 | -0.31 | -0.56 | 0.96 | 12.18 |
| Return on Assets (ROA) | -0.34 | -0.63 | -0.58 | -1.2 | -0.58 | -0.75 | -0.71 | -0.45 | -0.29 | -0.49 | -6.69 | n/a |
| Return on Capital (ROIC) | 63.10 | -1.69 | -1.02 | -3.29 | -1.08 | -1.07 | -0.83 | -0.49 | -0.31 | -0.55 | -12.73 | 9.90 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 97.62% | 99.78% | 99.62% | -463.66% | -121.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -35.88% | -46.35% | -88.58% | -599.76% | -191.66% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -35.19% | -45.93% | -85.67% | -597.59% | -196.47% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -38.31% | -46.23% | -85.24% | -595.42% | -199.49% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -35.89% | -44.47% | -50.98% | -452.45% | -136.59% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -38.13% | -51.89% | -85.24% | -593.05% | -197.92% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |